Marketing-authorisation holder · United States
Edenbridge Pharms
5 medicines in 1 country, as authorisation holder.
Group structure
Other companies in the group
United States1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
5 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE10mg; 6.25mg | 2.5mg; 6.25mg | 5mg; 6.25mg · Tablet | Bisoprolol, Hydrochlorothiazide | United States | Marketed | 2000 |
| DARTISLA ODT0.85mg | 1.7mg · Tablet, orally disintegrating | Glycopyrronium | United States | Not marketed | 2021 |
| DILTIAZEM HYDROCHLORIDE120mg | 30mg | 60mg | 90mg · Tablet | Diltiazem | United States | Marketed | 1992 |
| YARGESA100mg · Capsule | Miglustat | United States | Marketed | 2020 |
| ZUBSOLV0.7mg base; 0.18mg base | 1.4mg base; 0.36mg base | 11.4mg base; 2.9mg base | 2.9mg base; 0.71mg base | 5.7mg base; 1.4mg base | 8.6mg base; 2.1mg base · Tablet | Buprenorphine, Naloxone | United States | Marketed | 2013 |